{"id":9426,"date":"2022-05-20T08:00:47","date_gmt":"2022-05-20T08:00:47","guid":{"rendered":"https:\/\/ifpma.flywheelsites.com\/publications\/diversity-and-inclusion-in-clinical-trials-bioethical-perspective-and-principles\/"},"modified":"2024-06-17T11:27:10","modified_gmt":"2024-06-17T09:27:10","slug":"diversity-and-inclusion-in-clinical-trials-bioethical-perspective-and-principles","status":"publish","type":"publications","link":"https:\/\/www.ifpma.org\/publications\/diversity-and-inclusion-in-clinical-trials-bioethical-perspective-and-principles\/","title":{"rendered":"Diversity and Inclusion in Clinical Trials: Bioethical Perspective and Principles"},"content":{"rendered":"<p class=\"intro\">As IFPMA members, we believe that the knowledge gained from clinical trials should be used to support the development and use of innovative medicines, vaccines and other therapies, in order to develop the right treatment for the right patient.<\/p>\n<p>We believe that patient populations in clinical trials should be reflective of the epidemiology and demographics of those who would benefit from the therapeutic agent.<\/p>\n<p>To this end, we believe that diversity and inclusion in clinical trials is a matter of both equity and scientific rigor and, as such, that all individuals should have equal opportunity to participate in relevant clinical trials. The biopharmaceutical industry is committed to take affirmative steps to increase clinical trial diversity.<\/p>\n<p>&nbsp;<\/p>\n<p><img decoding=\"async\" src=\"http:\/\/ifpma.org\/wp-content\/uploads\/2023\/01\/i2023_IFPMA_Clinical-Trials-Diversity-Principles_16_05_2022-06.png\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>As IFPMA members, we believe that the knowledge gained from clinical trials should be used to support the development and use of innovative medicines, vaccines and other therapies, in order to develop the right treatment for the right patient.<\/p>\n","protected":false},"featured_media":16150,"template":"","publication_type":[7],"topic":[29],"class_list":["post-9426","publications","type-publications","status-publish","has-post-thumbnail","hentry","publication_type-position-paper","topic-ethics"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Diversity and Inclusion in Clinical Trials: Bioethical Perspective and Principles | IFPMA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ifpma.org\/publications\/diversity-and-inclusion-in-clinical-trials-bioethical-perspective-and-principles\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Diversity and Inclusion in Clinical Trials: Bioethical Perspective and Principles | IFPMA\" \/>\n<meta property=\"og:description\" content=\"As IFPMA members, we believe that the knowledge gained from clinical trials should be used to support the development and use of innovative medicines, vaccines and other therapies, in order to develop the right treatment for the right patient.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ifpma.org\/publications\/diversity-and-inclusion-in-clinical-trials-bioethical-perspective-and-principles\/\" \/>\n<meta property=\"og:site_name\" content=\"IFPMA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/IFPMA\/\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-17T09:27:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2022\/05\/NfG_Diversity-and-Inclusion-in-clinical-trials.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"634\" \/>\n\t<meta property=\"og:image:height\" content=\"896\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@IFPMA\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ifpma.org\/publications\/diversity-and-inclusion-in-clinical-trials-bioethical-perspective-and-principles\/\",\"url\":\"https:\/\/www.ifpma.org\/publications\/diversity-and-inclusion-in-clinical-trials-bioethical-perspective-and-principles\/\",\"name\":\"Diversity and Inclusion in Clinical Trials: Bioethical Perspective and Principles | IFPMA\",\"isPartOf\":{\"@id\":\"https:\/\/www.ifpma.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ifpma.org\/publications\/diversity-and-inclusion-in-clinical-trials-bioethical-perspective-and-principles\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ifpma.org\/publications\/diversity-and-inclusion-in-clinical-trials-bioethical-perspective-and-principles\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2022\/05\/NfG_Diversity-and-Inclusion-in-clinical-trials.webp\",\"datePublished\":\"2022-05-20T08:00:47+00:00\",\"dateModified\":\"2024-06-17T09:27:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ifpma.org\/publications\/diversity-and-inclusion-in-clinical-trials-bioethical-perspective-and-principles\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ifpma.org\/publications\/diversity-and-inclusion-in-clinical-trials-bioethical-perspective-and-principles\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ifpma.org\/publications\/diversity-and-inclusion-in-clinical-trials-bioethical-perspective-and-principles\/#primaryimage\",\"url\":\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2022\/05\/NfG_Diversity-and-Inclusion-in-clinical-trials.webp\",\"contentUrl\":\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2022\/05\/NfG_Diversity-and-Inclusion-in-clinical-trials.webp\",\"width\":634,\"height\":896},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ifpma.org\/publications\/diversity-and-inclusion-in-clinical-trials-bioethical-perspective-and-principles\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ifpma.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Publications\",\"item\":\"https:\/\/www.ifpma.org\/publications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Diversity and Inclusion in Clinical Trials: Bioethical Perspective and Principles\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ifpma.org\/#website\",\"url\":\"https:\/\/www.ifpma.org\/\",\"name\":\"IFPMA\",\"description\":\"Innovating to improve health worldwide\",\"publisher\":{\"@id\":\"https:\/\/www.ifpma.org\/#organization\"},\"alternateName\":\"International Federation of Pharmaceutical Manufacturers and Associations\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ifpma.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ifpma.org\/#organization\",\"name\":\"IFPMA\",\"alternateName\":\"International Federation of Pharmaceutical Manufacturers and Associations\",\"url\":\"https:\/\/www.ifpma.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ifpma.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2023\/04\/ifpma-logo-landscape-narrow.png\",\"contentUrl\":\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2023\/04\/ifpma-logo-landscape-narrow.png\",\"width\":1379,\"height\":733,\"caption\":\"IFPMA\"},\"image\":{\"@id\":\"https:\/\/www.ifpma.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/IFPMA\/\",\"https:\/\/x.com\/IFPMA\",\"https:\/\/www.linkedin.com\/company\/ifpma\/\",\"https:\/\/www.youtube.com\/user\/ifpma\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Diversity and Inclusion in Clinical Trials: Bioethical Perspective and Principles | IFPMA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ifpma.org\/publications\/diversity-and-inclusion-in-clinical-trials-bioethical-perspective-and-principles\/","og_locale":"en_US","og_type":"article","og_title":"Diversity and Inclusion in Clinical Trials: Bioethical Perspective and Principles | IFPMA","og_description":"As IFPMA members, we believe that the knowledge gained from clinical trials should be used to support the development and use of innovative medicines, vaccines and other therapies, in order to develop the right treatment for the right patient.","og_url":"https:\/\/www.ifpma.org\/publications\/diversity-and-inclusion-in-clinical-trials-bioethical-perspective-and-principles\/","og_site_name":"IFPMA","article_publisher":"https:\/\/www.facebook.com\/IFPMA\/","article_modified_time":"2024-06-17T09:27:10+00:00","og_image":[{"width":634,"height":896,"url":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2022\/05\/NfG_Diversity-and-Inclusion-in-clinical-trials.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_site":"@IFPMA","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ifpma.org\/publications\/diversity-and-inclusion-in-clinical-trials-bioethical-perspective-and-principles\/","url":"https:\/\/www.ifpma.org\/publications\/diversity-and-inclusion-in-clinical-trials-bioethical-perspective-and-principles\/","name":"Diversity and Inclusion in Clinical Trials: Bioethical Perspective and Principles | IFPMA","isPartOf":{"@id":"https:\/\/www.ifpma.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ifpma.org\/publications\/diversity-and-inclusion-in-clinical-trials-bioethical-perspective-and-principles\/#primaryimage"},"image":{"@id":"https:\/\/www.ifpma.org\/publications\/diversity-and-inclusion-in-clinical-trials-bioethical-perspective-and-principles\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2022\/05\/NfG_Diversity-and-Inclusion-in-clinical-trials.webp","datePublished":"2022-05-20T08:00:47+00:00","dateModified":"2024-06-17T09:27:10+00:00","breadcrumb":{"@id":"https:\/\/www.ifpma.org\/publications\/diversity-and-inclusion-in-clinical-trials-bioethical-perspective-and-principles\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ifpma.org\/publications\/diversity-and-inclusion-in-clinical-trials-bioethical-perspective-and-principles\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ifpma.org\/publications\/diversity-and-inclusion-in-clinical-trials-bioethical-perspective-and-principles\/#primaryimage","url":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2022\/05\/NfG_Diversity-and-Inclusion-in-clinical-trials.webp","contentUrl":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2022\/05\/NfG_Diversity-and-Inclusion-in-clinical-trials.webp","width":634,"height":896},{"@type":"BreadcrumbList","@id":"https:\/\/www.ifpma.org\/publications\/diversity-and-inclusion-in-clinical-trials-bioethical-perspective-and-principles\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ifpma.org\/"},{"@type":"ListItem","position":2,"name":"Publications","item":"https:\/\/www.ifpma.org\/publications\/"},{"@type":"ListItem","position":3,"name":"Diversity and Inclusion in Clinical Trials: Bioethical Perspective and Principles"}]},{"@type":"WebSite","@id":"https:\/\/www.ifpma.org\/#website","url":"https:\/\/www.ifpma.org\/","name":"IFPMA","description":"Innovating to improve health worldwide","publisher":{"@id":"https:\/\/www.ifpma.org\/#organization"},"alternateName":"International Federation of Pharmaceutical Manufacturers and Associations","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ifpma.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ifpma.org\/#organization","name":"IFPMA","alternateName":"International Federation of Pharmaceutical Manufacturers and Associations","url":"https:\/\/www.ifpma.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ifpma.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2023\/04\/ifpma-logo-landscape-narrow.png","contentUrl":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2023\/04\/ifpma-logo-landscape-narrow.png","width":1379,"height":733,"caption":"IFPMA"},"image":{"@id":"https:\/\/www.ifpma.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/IFPMA\/","https:\/\/x.com\/IFPMA","https:\/\/www.linkedin.com\/company\/ifpma\/","https:\/\/www.youtube.com\/user\/ifpma"]}]}},"_links":{"self":[{"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/publications\/9426","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/publications"}],"about":[{"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/types\/publications"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/media\/16150"}],"wp:attachment":[{"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/media?parent=9426"}],"wp:term":[{"taxonomy":"publication_type","embeddable":true,"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/publication_type?post=9426"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/topic?post=9426"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}